SCHEMBL2190000

SCHEMBL2190000

C=C(C)C(=O)OCC(O)COCCC[SiH](O[Si](C)(C)C)O[Si](C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.40
THRB P10828 1/20 0.35
ALDH1A1 P00352 1/20 0.31
POLB P06746 1/20 0.30
APEX1 P27695 1/20 0.30
HTT P42858 1/20 0.30
TDP1 Q9NUW8 1/20 0.30
LPAR5 Q9H1C0 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20045158 0.86
SCHEMBL29011421 0.84 TSHR (0.41) TSHRTHRBALDH1A1
SCHEMBL15882998 0.82 TSHR (0.45) TSHRTHRBALDH1A1POLBAPEX1
SCHEMBL29011418 0.82 TSHR (0.45) TSHRTHRBALDH1A1
SCHEMBL12799607 0.82 TSHR (0.35) TSHRTHRB
SCHEMBL7629287 0.82 TSHR (0.50) TSHRTHRBALDH1A1POLBAPEX1
SCHEMBL996289 0.82 TSHR (0.53) TSHRTHRBALDH1A1POLBAPEX1
SCHEMBL56496 0.82 TSHR (0.53) TSHRTHRBALDH1A1POLBAPEX1
SCHEMBL16901522 0.81 TSHR (0.44) TSHRTHRBALDH1A1POLBAPEX1
SCHEMBL35465 0.81 TSHR (0.41) TSHRTHRBALDH1A1LPAR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115819679-A Blue light resistant contact lenses and materials and methods for making same 望隼科技股份有限公司 2023-03-21 CN claimed
EP-2342588-B9 IONIC SILICONE HYDROGELS HAVING IMPROVED HYDROLYTIC STABILITY JOHNSON & JOHNSON VISION CARE (US) 2024-10-02 EP disclosed
EP-2342588-B1 IONIC SILICONE HYDROGELS HAVING IMPROVED HYDROLYTIC STABILITY JOHNSON & JOHNSON VISION CARE (US) 2024-07-03 EP disclosed
CN-115819679-A Blue light resistant contact lenses and materials and methods for making same 望隼科技股份有限公司 2023-03-21 CN disclosed
US-9851472-B2 Silicone-based hydrophilic copolymer and hydrogel compositions comprising the same MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2017-12-26 US disclosed
US-20160282517-A1 SILICONE-BASED HYDROPHILIC COPOLYMER AND HYDROGEL COMPOSITIONS COMPRISING THE SAME MOMENTIVE PERFORMANCE MATERIALS INC. 2016-09-29 US disclosed
US-9260544-B2 Ionic silicone hydrogels having improved hydrolytic stability JOHNSON & JOHNSON VISION CARE, INC. (US) 2016-02-16 US disclosed
US-9101667-B2 Ionic silicone hydrogels comprising pharmaceutical and/or neuticeutical components and having improved hydrolytic stability JOHNSON & JOHNSON VISION CARE, INC. (US) 2015-08-11 US disclosed
US-20140329859-A1 IONIC SILICONE HYDROGELS COMPRISING PHARMACEUTICAL AND/OR NEUTICEUTICAL COMPONENTS AND HAVING IMPROVED HYDROLYTIC STABILITY JOHNSON & JOHNSON VISION CARE (US) 2014-11-06 US disclosed
US-20140296440-A1 IONIC SILICONE HYDROGELS HAVING IMPROVED HYDROLYTIC STABILITY JOHNSON & JOHNSON VISION CARE (US) 2014-10-02 US disclosed
US-8815972-B2 Ionic silicone hydrogels having improved hydrolytic stability JOHNSON & JOHNSON VISION CARE, INC. (US) 2014-08-26 US disclosed
US-20130261215-A1 IONIC SILICONE HYDROGELS HAVING IMPROVED HYDROLYTIC STABILITY JOHNSON & JOHNSON VISION CARE, INC. (US) 2013-10-03 US disclosed
US-20130203812-A1 IONIC SILICONE HYDROGELS COMPRISING PHARMACEUTICAL AND/OR NUTRICEUTICAL COMPONENTS AND HAVING IMPROVED HYDROLYTIC STABILITY JOHNSON & JOHNSON VISION CARE, INC. (US) 2013-08-08 US disclosed
US-8470906-B2 Ionic silicone hydrogels having improved hydrolytic stability JOHNSON & JOHNSON VISION CARE, INC. (US) 2013-06-25 US disclosed
EP-2342588-A1 IONIC SILICONE HYDROGELS HAVING IMPROVED HYDROLYTIC STABILITY Johnson & Johnson Vision Care, Inc. (US) 2011-07-13 EP disclosed
US-20100249356-A1 IONIC SILICONE HYDROGELS HAVING IMPROVED HYDROLYTIC STABILITY JOHNSON & JOHNSON VISION CARE, INC. 2010-09-30 US disclosed
WO-2010039653-A1 IONIC SILICONE HYDROGELS HAVING IMPROVED HYDROLYTIC STABILITY JOHNSON & JOHNSON VISION CARE, INC. (US) 2010-04-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130203812-A1 IONIC SILICONE HYDROGELS COMPRISING PHARMACEUTICAL AND/OR NUTRICEUTICAL COMPONENTS AND HAVING IMPROVED HYDROLYTIC STABILITY IGFBP6, IGFBP1, IGFBP2 TSHR 2878/4885THRB 2874/4885ALDH1A1 3840/4885
US-20160282517-A1 SILICONE-BASED HYDROPHILIC COPOLYMER AND HYDROGEL COMPOSITIONS COMPRISING THE SAME RAD51, PLOD1, ILK TSHR 1598/4885THRB 1771/4885ALDH1A1 1954/4885
US-20140329859-A1 IONIC SILICONE HYDROGELS COMPRISING PHARMACEUTICAL AND/OR NEUTICEUTICAL COMPONENTS AND HAVING IMPROVED HYDROLYTIC STABILITY PIGS, PTMS, INHA TSHR 1582/4885THRB 1620/4885ALDH1A1 4175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.